Grosinger, Spigelman and Grey Eye Surgeons is participating in a research study (sponsored by a major intraocular lens manufacturing company) to collect data supporting the effectiveness of an investigational intraocular lens compared to an approved, marketed intraocular lens. “Investigational” means that the device being tested has not been approved by the United States Food and Drug Administration (FDA). The study involves the surgical implantation of an intraocular lens into both eyes and approximately 7 follow-up visits for up to 6 months after surgery. The investigational lens is designed to provide both intermediate (arms length) and far vision and may reduce your need for glasses. The approved, marketed intraocular lens is routinely used in many offices for cataract surgery. For more information, please call.